CARE vs MCBS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

CARE

57.3
AI Score
VS
CARE Wins

MCBS

51.7
AI Score

Investment Advisor Scores

CARE

57score
Recommendation
HOLD

MCBS

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CARE MCBS Winner
Forward P/E 13.6612 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 68.3% 33.9% CARE
Earnings Growth 253.9% 16.9% CARE
Tradestie Score 57.3/100 51.7/100 CARE
Profit Margin 44.9% 43.3% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CARE 1M: -2.7% · 3M: -7.4% MCBS 1M: -0.1% · 3M: -3.6%

Current Technical Phase

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $30.75

MCBS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.4 · Price: $35.23

Fundamentals Snapshot

Metric CARE MCBS
Market Cap — —
Forward P/E 11.8 10.8
Trailing P/E 5.2 12.1
Revenue (TTM) — —
Revenue Growth 0.7% 0.3%
Gross Margin 1.0% 1.0%
Operating Margin 0.6% 0.6%
EPS 5.89 2.88
Dividend Yield 0.00% 0.03%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.